|
J Biol Chem, Vol. 273, Issue 5, 2532-2542, January 30, 1998
Identification and Partial Purification of Human Double Strand
RNase Activity
A NOVEL TERMINATING MECHANISM FOR OLIGORIBONUCLEOTIDE ANTISENSE
DRUGS
Hongjiang
Wu,
A. Robert
MacLeod,
Walt F.
Lima, and
Stanley T.
Crooke
From the Department of Molecular Pharmacology, Isis
Pharmaceuticals, Carlsbad, California 92008
We have identified a double strand RNase
(dsRNase) activity that can serve as a novel mechanism for chimeric
antisense oligonucleotides comprised of 2 -methoxy 5 and 3
"wings" on either side of an oligoribonucleotide gap. Antisense
molecules targeted to the point mutation in codon 12 of Harvey Ras
(Ha-Ras) mRNA resulted in a dose-dependent reduction in
Ha-Ras RNA. Reduction in Ha-Ras RNA was dependent on the
oligoribonucleotide gap size with the minimum gap size being four
nucleotides. An antisense oligonucleotide of the same composition, but
containing four mismatches, was inactive.
When chimeric antisense oligonucleotides were prehybridized with 17-mer
oligoribonucleotides, extracts prepared from T24 cells, cytosol, and
nuclei resulted in cleavage in the oligoribonucleotide gap. Both
strands were cleaved. Neither mammalian nor Escherichia coli RNase HI cleaved the duplex, nor did single strand
nucleases. The dsRNase activity resulted in cleavage products with
5 -phosphate and 3 -hydroxyl termini.
Partial purification of dsRNase from rat liver cytosolic and nuclear
fractions was effected. The cytosolic enzyme was purified approximately
165-fold. It has an approximate molecular weight of 50,000-65,000, a
pH optimum of approximately 7.0, requires divalent cations, and is
inactivated by approximately 300 mM NaCl. It is inactivated
by heat, proteinase K, and also by a number of detergents and several
organic solvents.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. H. S. Hall, J. Wan, A. Spesock, Z. Sergueeva, B. R. Shaw, and K. A. Alexander
High potency silencing by single-stranded boranophosphate siRNA.
Nucleic Acids Res.,
January 1, 2006;
34(9):
2773 - 2781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Lodhi, M. H. Ozdener, and R. M. Shayiq
The Upstream Open Reading Frame Mediates Constitutive Effects on Translation of Cytochrome P-450c27 from the Seventh In-frame AUG Codon in Rat Liver
J. Biol. Chem.,
October 17, 2003;
278(42):
40647 - 40657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Vickers, S. Koo, C. F. Bennett, S. T. Crooke, N. M. Dean, and B. F. Baker
Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents. A COMPARATIVE ANALYSIS
J. Biol. Chem.,
February 21, 2003;
278(9):
7108 - 7118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Z. Yu, H. Zhang, R. S. Geary, M. Graham, L. Masarjian, K. Lemonidis, R. Crooke, N. M. Dean, and A. A. Levin
Pharmacokinetics and Pharmacodynamics of an Antisense Phosphorothioate Oligonucleotide Targeting Fas mRNA in Mice
J. Pharmacol. Exp. Ther.,
April 13, 2001;
296(2):
388 - 395.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Bramlage, E. Luzi, and F. Eckstein
HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture
Nucleic Acids Res.,
November 1, 2000;
28(21):
4059 - 4067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Lebedeva, R. Rando, J. Ojwang, P. Cossum, and C. A. Stein
Bcl-xL in Prostate Cancer Cells: Effects of Overexpression and Down-Regulation on Chemosensitivity
Cancer Res.,
November 1, 2000;
60(21):
6052 - 6060.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Kumar and G. G. Carmichael
Antisense RNA: Function and Fate of Duplex RNA in Cells of Higher Eukaryotes
Microbiol. Mol. Biol. Rev.,
December 1, 1998;
62(4):
1415 - 1434.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|